Category: Second Column

Briteside’s very bright video ad

Nancy Sajben, MD, forwarded this very well made ad for an Oregon delivery service, satirizing the drug-company commercials that forever emanate from our screens… Every touch —from the soccer mom opening sequence to the rapidfire listing of side effects at the end— is just right! Hats off to David Martin and the Communications team at Briteside Holdings. Big PhRMA is the ultimate upholder of marijuana prohibition. SCC founder Tod Mikuriya, MD, often made the point that marijuana use should be considered  in its real-world  context —as an alternative to pharmaceuticals and booze— and thus recognized as extremely safe. Ten years ago Jeffrey...

Read More

Inflammation a Cause of Alzheimer’s

Doesn’t this study in Neurology suggest that CBD —a potent anti-inflammatory— should be used prophylactically to ward off Alzheimer’s? The authors (led by Keenan A. Walker of John Hopkins) looked for markers of inflammation  —fibrinogen, albumin, white blood cell count, von Willebrand factor, and Factor VIII—  in the blood of middle-aged people (average age 53) who had taken part in the Atherosclerosis Risk in Communities Study in the early 1990s. Twenty four years later, 1,633 surviving participants took memory tests and had brain scans. Those with higher levels of inflammation in middle age did worse on the memory tests and showed...

Read More

Recommended Reading 11/2/17

From Bonni Goldstein, MD: A clear and compelling essay by EJ Sobo, PhD and Allison Ray Benavides, LCSW on the value of “experience-based knowledge.” Brief excerpts follow: “Many self-educated parents view doctors’ insistence on waiting for the go-ahead from pharmaceutical corporations or ‘big pharma’ as cowardly, if not complicit. They urge doctors to communicate with those who have, all along, been willing to help and who have the experience-based knowledge to do so. This is not an us-versus-them position; it is simply a request that doctors take a more critical look at what should count as evidence, particularly when...

Read More

MBC Cannabis ‘Agreement’

Provided with the materials for Agenda Item 18 at the October 27 MBC meeting: Appendix 2: Medicinal Cannabis Agreement 1 Date: ___________________________ I understand that _______________________ (clinician name) is helping me with the treatment of my medical illness. In considering the possibility of using medicinal cannabis, it is important to recognize that the risks of medicinal cannabis may be impacted by specific medical conditions and patterns of use. I understand what has been explained to me and agree to the following conditions of treatment: I understand that the course of treatment will be re-evaluated regularly after I begin treatment...

Read More

William Rehnquist, Drug Addict

Judge William Rehnquist, appointed to the US Supreme Court by Richard Nixon in 1971 and elevated to Chief Justice by Ronald Reagan in 1986, died in 2005. (George W. Bush named John Roberts to succeed him.)  Rehnquist’s obituaries ignored his longterm addiction to a pharmaceutical downer, Jack Shafer of Slate observed in a piece excerpted below: … For the nine years between 1972 and the end of 1981, William Rehnquist consumed great quantities of the potent sedative-hypnotic Placidyl. So great was Rehnquist’s Placidyl habit, dependency, or addiction —depending on how you regard long-term drug use—that by the last quarter...

Read More